nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.0263	0.0263	CcSEcCtD
Polythiazide—Hyperuricaemia—Thiotepa—urinary bladder cancer	0.0174	0.0174	CcSEcCtD
Polythiazide—Blood uric acid increased—Thiotepa—urinary bladder cancer	0.0164	0.0164	CcSEcCtD
Polythiazide—Vasculitis—Gemcitabine—urinary bladder cancer	0.0139	0.0139	CcSEcCtD
Polythiazide—Hyperuricaemia—Cisplatin—urinary bladder cancer	0.0136	0.0136	CcSEcCtD
Polythiazide—Blood uric acid increased—Cisplatin—urinary bladder cancer	0.0129	0.0129	CcSEcCtD
Polythiazide—Leukopenia—Mitomycin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Polythiazide—Hyperuricaemia—Etoposide—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Polythiazide—Asthenia—Valrubicin—urinary bladder cancer	0.0119	0.0119	CcSEcCtD
Polythiazide—Blood uric acid increased—Etoposide—urinary bladder cancer	0.0118	0.0118	CcSEcCtD
Polythiazide—Diarrhoea—Valrubicin—urinary bladder cancer	0.0114	0.0114	CcSEcCtD
Polythiazide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0112	0.0112	CcSEcCtD
Polythiazide—Photosensitivity—Fluorouracil—urinary bladder cancer	0.011	0.011	CcSEcCtD
Polythiazide—Dizziness—Valrubicin—urinary bladder cancer	0.011	0.011	CcSEcCtD
Polythiazide—Anorexia—Mitomycin—urinary bladder cancer	0.0109	0.0109	CcSEcCtD
Polythiazide—Vomiting—Valrubicin—urinary bladder cancer	0.0106	0.0106	CcSEcCtD
Polythiazide—Rash—Valrubicin—urinary bladder cancer	0.0105	0.0105	CcSEcCtD
Polythiazide—Dermatitis—Valrubicin—urinary bladder cancer	0.0105	0.0105	CcSEcCtD
Polythiazide—Headache—Valrubicin—urinary bladder cancer	0.0104	0.0104	CcSEcCtD
Polythiazide—Decreased appetite—Mitomycin—urinary bladder cancer	0.00994	0.00994	CcSEcCtD
Polythiazide—Nausea—Valrubicin—urinary bladder cancer	0.00986	0.00986	CcSEcCtD
Polythiazide—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00912	0.00912	CcSEcCtD
Polythiazide—Jaundice—Thiotepa—urinary bladder cancer	0.00879	0.00879	CcSEcCtD
Polythiazide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00841	0.00841	CcSEcCtD
Polythiazide—Orthostatic hypotension—Cisplatin—urinary bladder cancer	0.00838	0.00838	CcSEcCtD
Polythiazide—Cramp muscle—Cisplatin—urinary bladder cancer	0.00826	0.00826	CcSEcCtD
Polythiazide—Asthenia—Mitomycin—urinary bladder cancer	0.0082	0.0082	CcSEcCtD
Polythiazide—Glycosuria—Epirubicin—urinary bladder cancer	0.00801	0.00801	CcSEcCtD
Polythiazide—Diarrhoea—Mitomycin—urinary bladder cancer	0.00782	0.00782	CcSEcCtD
Polythiazide—Pancreatitis—Cisplatin—urinary bladder cancer	0.00777	0.00777	CcSEcCtD
Polythiazide—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00767	0.00767	CcSEcCtD
Polythiazide—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00763	0.00763	CcSEcCtD
Polythiazide—Cramp muscle—Etoposide—urinary bladder cancer	0.00757	0.00757	CcSEcCtD
Polythiazide—Dizziness—Mitomycin—urinary bladder cancer	0.00756	0.00756	CcSEcCtD
Polythiazide—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.00747	0.00747	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—urinary bladder cancer	0.00741	0.00741	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00738	0.00738	CcSEcCtD
Polythiazide—Vomiting—Mitomycin—urinary bladder cancer	0.00727	0.00727	CcSEcCtD
Polythiazide—Rash—Mitomycin—urinary bladder cancer	0.00721	0.00721	CcSEcCtD
Polythiazide—Dermatitis—Mitomycin—urinary bladder cancer	0.0072	0.0072	CcSEcCtD
Polythiazide—Headache—Mitomycin—urinary bladder cancer	0.00716	0.00716	CcSEcCtD
Polythiazide—Vasculitis—Methotrexate—urinary bladder cancer	0.0071	0.0071	CcSEcCtD
Polythiazide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00708	0.00708	CcSEcCtD
Polythiazide—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.00706	0.00706	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.00699	0.00699	CcSEcCtD
Polythiazide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00696	0.00696	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00683	0.00683	CcSEcCtD
Polythiazide—Nausea—Mitomycin—urinary bladder cancer	0.00679	0.00679	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.00661	0.00661	CcSEcCtD
Polythiazide—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00651	0.00651	CcSEcCtD
Polythiazide—Agitation—Thiotepa—urinary bladder cancer	0.00647	0.00647	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.00647	0.00647	CcSEcCtD
Polythiazide—Jaundice—Etoposide—urinary bladder cancer	0.00631	0.00631	CcSEcCtD
Polythiazide—Leukopenia—Thiotepa—urinary bladder cancer	0.00631	0.00631	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.00611	0.00611	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00609	0.00609	CcSEcCtD
Polythiazide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00604	0.00604	CcSEcCtD
Polythiazide—Photosensitivity—Methotrexate—urinary bladder cancer	0.00573	0.00573	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00564	0.00564	CcSEcCtD
Polythiazide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00563	0.00563	CcSEcCtD
Polythiazide—Anorexia—Thiotepa—urinary bladder cancer	0.00548	0.00548	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—urinary bladder cancer	0.00536	0.00536	CcSEcCtD
Polythiazide—Muscle spasms—Cisplatin—urinary bladder cancer	0.00531	0.00531	CcSEcCtD
Polythiazide—Leukopenia—Gemcitabine—urinary bladder cancer	0.0053	0.0053	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—urinary bladder cancer	0.00527	0.00527	CcSEcCtD
Polythiazide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00522	0.00522	CcSEcCtD
Polythiazide—Paraesthesia—Thiotepa—urinary bladder cancer	0.00516	0.00516	CcSEcCtD
Polythiazide—Decreased appetite—Thiotepa—urinary bladder cancer	0.005	0.005	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—urinary bladder cancer	0.00496	0.00496	CcSEcCtD
Polythiazide—Leukopenia—Cisplatin—urinary bladder cancer	0.00494	0.00494	CcSEcCtD
Polythiazide—Constipation—Thiotepa—urinary bladder cancer	0.00492	0.00492	CcSEcCtD
Polythiazide—Purpura—Epirubicin—urinary bladder cancer	0.00489	0.00489	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00487	0.00487	CcSEcCtD
Polythiazide—Muscle spasms—Etoposide—urinary bladder cancer	0.00487	0.00487	CcSEcCtD
Polythiazide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00474	0.00474	CcSEcCtD
Polythiazide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Polythiazide—Anorexia—Gemcitabine—urinary bladder cancer	0.00461	0.00461	CcSEcCtD
Polythiazide—Urticaria—Thiotepa—urinary bladder cancer	0.00457	0.00457	CcSEcCtD
Polythiazide—Vertigo—Etoposide—urinary bladder cancer	0.00455	0.00455	CcSEcCtD
Polythiazide—Anorexia—Fluorouracil—urinary bladder cancer	0.00453	0.00453	CcSEcCtD
Polythiazide—Leukopenia—Etoposide—urinary bladder cancer	0.00453	0.00453	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—urinary bladder cancer	0.00452	0.00452	CcSEcCtD
Polythiazide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00441	0.00441	CcSEcCtD
Polythiazide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00434	0.00434	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Polythiazide—Anorexia—Cisplatin—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Polythiazide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00427	0.00427	CcSEcCtD
Polythiazide—Pancreatitis—Methotrexate—urinary bladder cancer	0.00427	0.00427	CcSEcCtD
Polythiazide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00424	0.00424	CcSEcCtD
Polythiazide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.0042	0.0042	CcSEcCtD
Polythiazide—Constipation—Gemcitabine—urinary bladder cancer	0.00414	0.00414	CcSEcCtD
Polythiazide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Polythiazide—Asthenia—Thiotepa—urinary bladder cancer	0.00413	0.00413	CcSEcCtD
Polythiazide—Paraesthesia—Cisplatin—urinary bladder cancer	0.00405	0.00405	CcSEcCtD
Polythiazide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—urinary bladder cancer	0.00399	0.00399	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Polythiazide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00397	0.00397	CcSEcCtD
Polythiazide—Anorexia—Etoposide—urinary bladder cancer	0.00394	0.00394	CcSEcCtD
Polythiazide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00393	0.00393	CcSEcCtD
Polythiazide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Polythiazide—Dizziness—Thiotepa—urinary bladder cancer	0.0038	0.0038	CcSEcCtD
Polythiazide—Urticaria—Fluorouracil—urinary bladder cancer	0.00378	0.00378	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00372	0.00372	CcSEcCtD
Polythiazide—Paraesthesia—Etoposide—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00369	0.00369	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00367	0.00367	CcSEcCtD
Polythiazide—Vomiting—Thiotepa—urinary bladder cancer	0.00366	0.00366	CcSEcCtD
Polythiazide—Rash—Thiotepa—urinary bladder cancer	0.00363	0.00363	CcSEcCtD
Polythiazide—Dermatitis—Thiotepa—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Headache—Thiotepa—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Polythiazide—Decreased appetite—Etoposide—urinary bladder cancer	0.00359	0.00359	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—urinary bladder cancer	0.00354	0.00354	CcSEcCtD
Polythiazide—Constipation—Etoposide—urinary bladder cancer	0.00353	0.00353	CcSEcCtD
Polythiazide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0035	0.0035	CcSEcCtD
Polythiazide—Asthenia—Gemcitabine—urinary bladder cancer	0.00347	0.00347	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Polythiazide—Nausea—Thiotepa—urinary bladder cancer	0.00342	0.00342	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Polythiazide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Polythiazide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Polythiazide—Urticaria—Etoposide—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Polythiazide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00325	0.00325	CcSEcCtD
Polythiazide—Asthenia—Cisplatin—urinary bladder cancer	0.00323	0.00323	CcSEcCtD
Polythiazide—Dizziness—Fluorouracil—urinary bladder cancer	0.00314	0.00314	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Polythiazide—Diarrhoea—Cisplatin—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Polythiazide—Vomiting—Gemcitabine—urinary bladder cancer	0.00308	0.00308	CcSEcCtD
Polythiazide—Rash—Gemcitabine—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Polythiazide—Dermatitis—Gemcitabine—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Polythiazide—Hypersensitivity—Etoposide—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Polythiazide—Headache—Gemcitabine—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Polythiazide—Vomiting—Fluorouracil—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Polythiazide—Rash—Fluorouracil—urinary bladder cancer	0.003	0.003	CcSEcCtD
Polythiazide—Dermatitis—Fluorouracil—urinary bladder cancer	0.003	0.003	CcSEcCtD
Polythiazide—Headache—Fluorouracil—urinary bladder cancer	0.00298	0.00298	CcSEcCtD
Polythiazide—Asthenia—Etoposide—urinary bladder cancer	0.00296	0.00296	CcSEcCtD
Polythiazide—Nausea—Gemcitabine—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Polythiazide—Vomiting—Cisplatin—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Polythiazide—Rash—Cisplatin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Polythiazide—Dermatitis—Cisplatin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Polythiazide—Diarrhoea—Etoposide—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Polythiazide—Nausea—Fluorouracil—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Polythiazide—Dizziness—Etoposide—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—urinary bladder cancer	0.00273	0.00273	CcSEcCtD
Polythiazide—Vertigo—Methotrexate—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Polythiazide—Leukopenia—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Polythiazide—Nausea—Cisplatin—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Polythiazide—Vomiting—Etoposide—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Polythiazide—Agitation—Epirubicin—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Polythiazide—Rash—Etoposide—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Polythiazide—Dermatitis—Etoposide—urinary bladder cancer	0.0026	0.0026	CcSEcCtD
Polythiazide—Headache—Etoposide—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—urinary bladder cancer	0.00254	0.00254	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Polythiazide—Nausea—Etoposide—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Polythiazide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Polythiazide—Anorexia—Methotrexate—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Polythiazide—Paraesthesia—Methotrexate—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Polythiazide—Decreased appetite—Methotrexate—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Polythiazide—Constipation—Epirubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Polythiazide—Urticaria—Methotrexate—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Polythiazide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Polythiazide—Asthenia—Methotrexate—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Polythiazide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Polythiazide—Diarrhoea—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Polythiazide—Dizziness—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Polythiazide—Vomiting—Methotrexate—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Polythiazide—Rash—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Polythiazide—Dermatitis—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Polythiazide—Headache—Methotrexate—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Polythiazide—Nausea—Methotrexate—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Polythiazide—Rash—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Polythiazide—Headache—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Polythiazide—Nausea—Epirubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Polythiazide—Rash—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Polythiazide—Headache—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
